167 related articles for article (PubMed ID: 19000723)
1. Human immunodeficiency virus type 1 chronic infection is associated with different gene expression in MT-4, H9 and U937 cell lines.
Olivares I; Ballester A; Lombardia L; Dominguez O; López-Galíndez C
Virus Res; 2009 Jan; 139(1):22-31. PubMed ID: 19000723
[TBL] [Abstract][Full Text] [Related]
2. Genetic changes associated with distinct patterns of HIV type 1 persistence in chronically infected cell lines.
Sanchez-Merino V; Muñoz L; Pérez-Pastrana ME; Herrera MI; Olivares I; Lopez-Galindez C
AIDS Res Hum Retroviruses; 2007 Feb; 23(2):251-60. PubMed ID: 17331031
[TBL] [Abstract][Full Text] [Related]
3. HIV-1 infection initiates changes in the expression of a wide array of genes in U937 promonocytes and HUT78 T cells.
Wen W; Chen S; Cao Y; Zhu Y; Yamamoto Y
Virus Res; 2005 Oct; 113(1):26-35. PubMed ID: 15885842
[TBL] [Abstract][Full Text] [Related]
4. Host cell gene expression during human immunodeficiency virus type 1 latency and reactivation and effects of targeting genes that are differentially expressed in viral latency.
Krishnan V; Zeichner SL
J Virol; 2004 Sep; 78(17):9458-73. PubMed ID: 15308739
[TBL] [Abstract][Full Text] [Related]
5. RNA interference and HIV-1 infection.
Kanzaki LI; Ornelas SS; Argañaraz ER
Rev Med Virol; 2008; 18(1):5-18. PubMed ID: 17764099
[TBL] [Abstract][Full Text] [Related]
6. Human immunodeficiency virus type 1 infection of human uterine epithelial cells: viral shedding and cell contact-mediated infectivity.
Asin SN; Wildt-Perinic D; Mason SI; Howell AL; Wira CR; Fanger MW
J Infect Dis; 2003 May; 187(10):1522-33. PubMed ID: 12721932
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of HIV-1 replication and reactivation from latency by tat transdominant negative mutants in the cysteine rich region.
Caputo A; Grossi MP; Bozzini R; Rossi C; Betti M; Marconi PC; Barbanti-Brodano G; Balboni PG
Gene Ther; 1996 Mar; 3(3):235-45. PubMed ID: 8646555
[TBL] [Abstract][Full Text] [Related]
8. Viral and host cofactors facilitate HIV-1 replication in macrophages.
Wahl SM; Greenwell-Wild T; Peng G; Ma G; Orenstein JM; Vazquez N
J Leukoc Biol; 2003 Nov; 74(5):726-35. PubMed ID: 12960226
[TBL] [Abstract][Full Text] [Related]
9. Identification of cell surface targets for HIV-1 therapeutics using genetic screens.
Dunn SJ; Khan IH; Chan UA; Scearce RL; Melara CL; Paul AM; Sharma V; Bih FY; Holzmayer TA; Luciw PA; Abo A
Virology; 2004 Apr; 321(2):260-73. PubMed ID: 15051386
[TBL] [Abstract][Full Text] [Related]
10. Gene expression profiling of the host response to HIV-1 B, C, or A/E infection in monocyte-derived dendritic cells.
Solis M; Wilkinson P; Romieu R; Hernandez E; Wainberg MA; Hiscott J
Virology; 2006 Aug; 352(1):86-99. PubMed ID: 16730773
[TBL] [Abstract][Full Text] [Related]
11. Centrosomal pre-integration latency of HIV-1 in quiescent cells.
Zamborlini A; Lehmann-Che J; Clave E; Giron ML; Tobaly-Tapiero J; Roingeard P; Emiliani S; Toubert A; de Thé H; Saïb A
Retrovirology; 2007 Sep; 4():63. PubMed ID: 17845727
[TBL] [Abstract][Full Text] [Related]
12. Molecular biology of human immunodeficiency virus type 1.
Wang WK; Chen MY; Chuang CY; Jeang KT; Huang LM
J Microbiol Immunol Infect; 2000 Sep; 33(3):131-40. PubMed ID: 11045374
[TBL] [Abstract][Full Text] [Related]
13. Rates of shutdown of HIV-1 into latency: roles of the LTR and tat/rev/vpu gene region.
Song SK; Li H; Cloyd MW
Virology; 1996 Nov; 225(2):377-86. PubMed ID: 8918924
[TBL] [Abstract][Full Text] [Related]
14. Determination of HIV-1 infectivity by lymphocytic cell lines with integrated luciferase gene.
Nagao T; Yoshida A; Sakurai A; Piroozmand A; Jere A; Fujita M; Uchiyama T; Adachi A
Int J Mol Med; 2004 Dec; 14(6):1073-6. PubMed ID: 15547676
[TBL] [Abstract][Full Text] [Related]
15. Functional genomic relationships in HIV-1 disease revealed by gene-expression profiling of primary human peripheral blood mononuclear cells.
Ockenhouse CF; Bernstein WB; Wang Z; Vahey MT
J Infect Dis; 2005 Jun; 191(12):2064-74. PubMed ID: 15897992
[TBL] [Abstract][Full Text] [Related]
16. Dual activity of phosphorothioate CpG oligodeoxynucleotides on HIV: reactivation of latent provirus and inhibition of productive infection in human T cells.
Scheller C; Ullrich A; Lamla S; Dittmer U; Rethwilm A; Koutsilieri E
Ann N Y Acad Sci; 2006 Dec; 1091():540-7. PubMed ID: 17341643
[TBL] [Abstract][Full Text] [Related]
17. Identification of a host gene subset related to disease prognosis of HIV-1 infected individuals.
Motomura K; Toyoda N; Oishi K; Sato H; Nagai S; Hashimoto S; Tugume SB; Enzama R; Mugewa R; Mutuluuza CK; Mugyeyi P; Nagatake T; Matsushima K
Int Immunopharmacol; 2004 Dec; 4(14):1829-36. PubMed ID: 15531298
[TBL] [Abstract][Full Text] [Related]
18. Poly(ADP-ribose) polymerase activity in various U937 cell subclones with different susceptibility to HIV-1 infection: its dramatic decrease following persistent virus infection.
Tanaka Y; Yoshihara K; Kojima K; Itaya A; Kameoka M; Ikuta K; Kamiya T
Biochem Biophys Res Commun; 1995 Aug; 213(1):161-8. PubMed ID: 7639731
[TBL] [Abstract][Full Text] [Related]
19. TLR5 stimulation is sufficient to trigger reactivation of latent HIV-1 provirus in T lymphoid cells and activate virus gene expression in central memory CD4+ T cells.
Thibault S; Imbeault M; Tardif MR; Tremblay MJ
Virology; 2009 Jun; 389(1-2):20-5. PubMed ID: 19447460
[TBL] [Abstract][Full Text] [Related]
20. Heterogeneity in HIV and cellular transcription profiles in cell line models of latent and productive infection: implications for HIV latency.
Telwatte S; Morón-López S; Aran D; Kim P; Hsieh C; Joshi S; Montano M; Greene WC; Butte AJ; Wong JK; Yukl SA
Retrovirology; 2019 Nov; 16(1):32. PubMed ID: 31711503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
